Market Report, "Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) - Pipeline Review, H2 2012", Published
Global Markets Direct's, 'Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy). Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy)...
View full press release